nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—Toremifene—breast cancer	0.25	0.614	CrCtD
Loperamide—Tamoxifen—breast cancer	0.157	0.386	CrCtD
Loperamide—CYP2D6—breast cancer	0.0436	0.389	CbGaD
Loperamide—CYP3A4—breast cancer	0.0374	0.334	CbGaD
Loperamide—Cloperastine—Raloxifene—breast cancer	0.0312	0.166	CrCrCtD
Loperamide—ABCB1—breast cancer	0.0312	0.278	CbGaD
Loperamide—Tamoxifen—Toremifene—breast cancer	0.0272	0.144	CrCrCtD
Loperamide—Toremifene—Tamoxifen—breast cancer	0.0249	0.132	CrCrCtD
Loperamide—Dextropropoxyphene—Toremifene—breast cancer	0.0216	0.115	CrCrCtD
Loperamide—Methadyl Acetate—Tamoxifen—breast cancer	0.0165	0.0878	CrCrCtD
Loperamide—Levomethadyl Acetate—Tamoxifen—breast cancer	0.0165	0.0878	CrCrCtD
Loperamide—Clofedanol—Toremifene—breast cancer	0.0156	0.083	CrCrCtD
Loperamide—Dextropropoxyphene—Tamoxifen—breast cancer	0.0136	0.0721	CrCrCtD
Loperamide—CYP2B6—Thiotepa—breast cancer	0.0131	0.0793	CbGbCtD
Loperamide—Methadone—Tamoxifen—breast cancer	0.0114	0.0603	CrCrCtD
Loperamide—Clofedanol—Tamoxifen—breast cancer	0.00982	0.0521	CrCrCtD
Loperamide—CYP2B6—Raloxifene—breast cancer	0.00875	0.0529	CbGbCtD
Loperamide—CYP2C8—Lapatinib—breast cancer	0.00874	0.0529	CbGbCtD
Loperamide—ABCB1—Toremifene—breast cancer	0.00811	0.0491	CbGbCtD
Loperamide—CYP3A4—Exemestane—breast cancer	0.00701	0.0424	CbGbCtD
Loperamide—CYP2C8—Raloxifene—breast cancer	0.00662	0.0401	CbGbCtD
Loperamide—CYP2D6—Idarubicin—breast cancer	0.00633	0.0383	CbGbCtD
Loperamide—CYP3A4—Letrozole—breast cancer	0.00596	0.0361	CbGbCtD
Loperamide—ABCB1—Lapatinib—breast cancer	0.00592	0.0358	CbGbCtD
Loperamide—CYP2B6—Tamoxifen—breast cancer	0.00578	0.035	CbGbCtD
Loperamide—CYP3A4—Anastrozole—breast cancer	0.00531	0.0321	CbGbCtD
Loperamide—CYP3A4—Toremifene—breast cancer	0.00486	0.0294	CbGbCtD
Loperamide—CYP3A4—Fulvestrant—breast cancer	0.00452	0.0273	CbGbCtD
Loperamide—CYP2B6—Irinotecan—breast cancer	0.00444	0.0268	CbGbCtD
Loperamide—CYP2C8—Tamoxifen—breast cancer	0.00438	0.0265	CbGbCtD
Loperamide—CYP3A4—Thiotepa—breast cancer	0.00403	0.0244	CbGbCtD
Loperamide—CYP3A4—Ixabepilone—breast cancer	0.00368	0.0223	CbGbCtD
Loperamide—CYP3A4—Lapatinib—breast cancer	0.00354	0.0214	CbGbCtD
Loperamide—CYP2C8—Paclitaxel—breast cancer	0.00341	0.0206	CbGbCtD
Loperamide—ABCB1—Vinorelbine—breast cancer	0.00328	0.0199	CbGbCtD
Loperamide—CYP2C8—Fluorouracil—breast cancer	0.00323	0.0195	CbGbCtD
Loperamide—CYP2D6—Vinorelbine—breast cancer	0.00309	0.0187	CbGbCtD
Loperamide—ABCB1—Tamoxifen—breast cancer	0.00296	0.0179	CbGbCtD
Loperamide—ABCB1—Mitoxantrone—breast cancer	0.00289	0.0175	CbGbCtD
Loperamide—CYP2D6—Tamoxifen—breast cancer	0.00279	0.0169	CbGbCtD
Loperamide—CYP3A4—Raloxifene—breast cancer	0.00269	0.0162	CbGbCtD
Loperamide—ABCB1—Gemcitabine—breast cancer	0.00255	0.0154	CbGbCtD
Loperamide—CYP2B6—Doxorubicin—breast cancer	0.00242	0.0147	CbGbCtD
Loperamide—ABCB1—Paclitaxel—breast cancer	0.00231	0.0139	CbGbCtD
Loperamide—ABCB1—Irinotecan—breast cancer	0.00227	0.0138	CbGbCtD
Loperamide—ABCB1—Vinblastine—breast cancer	0.00202	0.0122	CbGbCtD
Loperamide—CYP3A4—Vinorelbine—breast cancer	0.00197	0.0119	CbGbCtD
Loperamide—CYP2D6—Vinblastine—breast cancer	0.00191	0.0115	CbGbCtD
Loperamide—CYP3A4—Tamoxifen—breast cancer	0.00178	0.0107	CbGbCtD
Loperamide—CYP3A4—Mitoxantrone—breast cancer	0.00173	0.0105	CbGbCtD
Loperamide—ABCB1—Docetaxel—breast cancer	0.00167	0.0101	CbGbCtD
Loperamide—CYP3A4—Paclitaxel—breast cancer	0.00138	0.00836	CbGbCtD
Loperamide—CYP3A4—Irinotecan—breast cancer	0.00136	0.00824	CbGbCtD
Loperamide—ABCB1—Doxorubicin—breast cancer	0.00124	0.00752	CbGbCtD
Loperamide—CYP3A4—Vinblastine—breast cancer	0.00121	0.00733	CbGbCtD
Loperamide—ABCB1—Methotrexate—breast cancer	0.0012	0.00728	CbGbCtD
Loperamide—CYP2D6—Doxorubicin—breast cancer	0.00117	0.00708	CbGbCtD
Loperamide—CYP3A4—Docetaxel—breast cancer	0.000999	0.00604	CbGbCtD
Loperamide—CYP3A4—Doxorubicin—breast cancer	0.000745	0.0045	CbGbCtD
Loperamide—POMC—skin of body—breast cancer	0.000716	0.0473	CbGeAlD
Loperamide—POMC—pituitary gland—breast cancer	0.000611	0.0404	CbGeAlD
Loperamide—POMC—adipose tissue—breast cancer	0.000608	0.0402	CbGeAlD
Loperamide—POMC—female reproductive system—breast cancer	0.000559	0.037	CbGeAlD
Loperamide—POMC—adrenal gland—breast cancer	0.000545	0.0361	CbGeAlD
Loperamide—CACNA1A—adrenal gland—breast cancer	0.000521	0.0344	CbGeAlD
Loperamide—POMC—female gonad—breast cancer	0.000509	0.0336	CbGeAlD
Loperamide—POMC—endocrine gland—breast cancer	0.000473	0.0313	CbGeAlD
Loperamide—CALM3—mammary gland—breast cancer	0.00047	0.0311	CbGeAlD
Loperamide—CALM3—nipple—breast cancer	0.000389	0.0257	CbGeAlD
Loperamide—CALM1—mammary gland—breast cancer	0.000367	0.0243	CbGeAlD
Loperamide—CYP2C8—mammary gland—breast cancer	0.000306	0.0202	CbGeAlD
Loperamide—CALM2—nipple—breast cancer	0.000305	0.0202	CbGeAlD
Loperamide—CALM1—nipple—breast cancer	0.000304	0.0201	CbGeAlD
Loperamide—OPRK1—female reproductive system—breast cancer	0.000296	0.0195	CbGeAlD
Loperamide—CALM2—embryo—breast cancer	0.000252	0.0166	CbGeAlD
Loperamide—CALM1—embryo—breast cancer	0.000251	0.0166	CbGeAlD
Loperamide—Clotrimazole—KCNN4—breast cancer	0.000244	0.145	CrCbGaD
Loperamide—CALM3—endometrium—breast cancer	0.000235	0.0155	CbGeAlD
Loperamide—CALM3—uterus—breast cancer	0.000216	0.0143	CbGeAlD
Loperamide—CALM3—pituitary gland—breast cancer	0.000212	0.014	CbGeAlD
Loperamide—CALM3—adipose tissue—breast cancer	0.000211	0.014	CbGeAlD
Loperamide—CALM2—epithelium—breast cancer	0.000205	0.0136	CbGeAlD
Loperamide—CALM1—epithelium—breast cancer	0.000205	0.0135	CbGeAlD
Loperamide—CALM2—skin of body—breast cancer	0.000195	0.0129	CbGeAlD
Loperamide—CALM1—skin of body—breast cancer	0.000195	0.0129	CbGeAlD
Loperamide—CALM3—adrenal gland—breast cancer	0.00019	0.0125	CbGeAlD
Loperamide—CALM2—endometrium—breast cancer	0.000184	0.0122	CbGeAlD
Loperamide—CALM3—bone marrow—breast cancer	0.000184	0.0121	CbGeAlD
Loperamide—CALM1—endometrium—breast cancer	0.000183	0.0121	CbGeAlD
Loperamide—OPRM1—endocrine gland—breast cancer	0.000178	0.0118	CbGeAlD
Loperamide—Tamoxifen—ESRRA—breast cancer	0.000177	0.105	CrCbGaD
Loperamide—CALM3—female gonad—breast cancer	0.000177	0.0117	CbGeAlD
Loperamide—CALM2—uterus—breast cancer	0.00017	0.0112	CbGeAlD
Loperamide—CALM1—uterus—breast cancer	0.000169	0.0112	CbGeAlD
Loperamide—CALM2—pituitary gland—breast cancer	0.000167	0.011	CbGeAlD
Loperamide—CALM2—adipose tissue—breast cancer	0.000166	0.011	CbGeAlD
Loperamide—CALM1—pituitary gland—breast cancer	0.000166	0.011	CbGeAlD
Loperamide—CALM1—adipose tissue—breast cancer	0.000165	0.0109	CbGeAlD
Loperamide—CYP2C8—endometrium—breast cancer	0.000153	0.0101	CbGeAlD
Loperamide—CALM2—female reproductive system—breast cancer	0.000153	0.0101	CbGeAlD
Loperamide—CALM1—female reproductive system—breast cancer	0.000152	0.01	CbGeAlD
Loperamide—CALM2—adrenal gland—breast cancer	0.000149	0.00985	CbGeAlD
Loperamide—CALM1—adrenal gland—breast cancer	0.000148	0.0098	CbGeAlD
Loperamide—CYP2B6—skin of body—breast cancer	0.000145	0.00961	CbGeAlD
Loperamide—CALM2—bone marrow—breast cancer	0.000144	0.00953	CbGeAlD
Loperamide—CALM1—bone marrow—breast cancer	0.000143	0.00948	CbGeAlD
Loperamide—CALM2—female gonad—breast cancer	0.000139	0.00918	CbGeAlD
Loperamide—CALM1—female gonad—breast cancer	0.000138	0.00914	CbGeAlD
Loperamide—CYP2C8—pituitary gland—breast cancer	0.000138	0.00914	CbGeAlD
Loperamide—Tamoxifen—SULT1A1—breast cancer	0.000134	0.0796	CrCbGaD
Loperamide—CALM2—endocrine gland—breast cancer	0.000129	0.00854	CbGeAlD
Loperamide—CALM1—endocrine gland—breast cancer	0.000129	0.0085	CbGeAlD
Loperamide—CYP2C8—female reproductive system—breast cancer	0.000127	0.00836	CbGeAlD
Loperamide—Fexofenadine—SLCO1B1—breast cancer	0.000119	0.0708	CrCbGaD
Loperamide—CALM3—lymph node—breast cancer	0.000114	0.00752	CbGeAlD
Loperamide—CYP2B6—female reproductive system—breast cancer	0.000113	0.0075	CbGeAlD
Loperamide—CYP2B6—adrenal gland—breast cancer	0.000111	0.00732	CbGeAlD
Loperamide—CYP2C8—endocrine gland—breast cancer	0.000107	0.00708	CbGeAlD
Loperamide—ABCB1—embryo—breast cancer	0.0001	0.00662	CbGeAlD
Loperamide—CYP2B6—endocrine gland—breast cancer	9.6e-05	0.00635	CbGeAlD
Loperamide—CALM2—lymph node—breast cancer	8.93e-05	0.0059	CbGeAlD
Loperamide—CALM1—lymph node—breast cancer	8.89e-05	0.00588	CbGeAlD
Loperamide—CYP3A4—female reproductive system—breast cancer	8.57e-05	0.00567	CbGeAlD
Loperamide—CYP2D6—female reproductive system—breast cancer	8.43e-05	0.00558	CbGeAlD
Loperamide—Clotrimazole—CYP17A1—breast cancer	8.4e-05	0.0498	CrCbGaD
Loperamide—ABCB1—epithelium—breast cancer	8.17e-05	0.0054	CbGeAlD
Loperamide—CYP2D6—female gonad—breast cancer	7.67e-05	0.00507	CbGeAlD
Loperamide—ABCB1—endometrium—breast cancer	7.32e-05	0.00484	CbGeAlD
Loperamide—CYP3A4—endocrine gland—breast cancer	7.25e-05	0.00479	CbGeAlD
Loperamide—CYP2D6—endocrine gland—breast cancer	7.14e-05	0.00472	CbGeAlD
Loperamide—ABCB1—uterus—breast cancer	6.75e-05	0.00446	CbGeAlD
Loperamide—ABCB1—pituitary gland—breast cancer	6.63e-05	0.00438	CbGeAlD
Loperamide—ABCB1—adipose tissue—breast cancer	6.6e-05	0.00436	CbGeAlD
Loperamide—ABCB1—female reproductive system—breast cancer	6.07e-05	0.00401	CbGeAlD
Loperamide—ABCB1—adrenal gland—breast cancer	5.92e-05	0.00391	CbGeAlD
Loperamide—Toremifene—ESR1—breast cancer	5.82e-05	0.0346	CrCbGaD
Loperamide—ABCB1—bone marrow—breast cancer	5.73e-05	0.00379	CbGeAlD
Loperamide—ABCB1—female gonad—breast cancer	5.52e-05	0.00365	CbGeAlD
Loperamide—ABCB1—endocrine gland—breast cancer	5.13e-05	0.00339	CbGeAlD
Loperamide—Toremifene—CYP1A1—breast cancer	4.65e-05	0.0276	CrCbGaD
Loperamide—Dermatitis—Melphalan—breast cancer	4.63e-05	0.000908	CcSEcCtD
Loperamide—Asthenia—Vinorelbine—breast cancer	4.61e-05	0.000904	CcSEcCtD
Loperamide—Nausea—Vinblastine—breast cancer	4.59e-05	0.0009	CcSEcCtD
Loperamide—Abdominal pain upper—Epirubicin—breast cancer	4.59e-05	0.0009	CcSEcCtD
Loperamide—Somnolence—Gemcitabine—breast cancer	4.59e-05	0.0009	CcSEcCtD
Loperamide—Gastrointestinal disorder—Irinotecan—breast cancer	4.57e-05	0.000897	CcSEcCtD
Loperamide—Fatigue—Irinotecan—breast cancer	4.57e-05	0.000896	CcSEcCtD
Loperamide—Fatigue—Mitoxantrone—breast cancer	4.57e-05	0.000896	CcSEcCtD
Loperamide—Vomiting—Goserelin—breast cancer	4.56e-05	0.000894	CcSEcCtD
Loperamide—Pruritus—Vinorelbine—breast cancer	4.54e-05	0.000891	CcSEcCtD
Loperamide—Constipation—Mitoxantrone—breast cancer	4.53e-05	0.000888	CcSEcCtD
Loperamide—Constipation—Irinotecan—breast cancer	4.53e-05	0.000888	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Epirubicin—breast cancer	4.53e-05	0.000887	CcSEcCtD
Loperamide—Rash—Goserelin—breast cancer	4.52e-05	0.000887	CcSEcCtD
Loperamide—Hypersensitivity—Thiotepa—breast cancer	4.52e-05	0.000886	CcSEcCtD
Loperamide—Dermatitis—Goserelin—breast cancer	4.52e-05	0.000886	CcSEcCtD
Loperamide—Somnolence—Fluorouracil—breast cancer	4.51e-05	0.000884	CcSEcCtD
Loperamide—Immune system disorder—Capecitabine—breast cancer	4.51e-05	0.000884	CcSEcCtD
Loperamide—Headache—Goserelin—breast cancer	4.49e-05	0.000881	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	4.48e-05	0.000878	CcSEcCtD
Loperamide—Dyspepsia—Fluorouracil—breast cancer	4.47e-05	0.000876	CcSEcCtD
Loperamide—Nausea—Tamoxifen—breast cancer	4.46e-05	0.000875	CcSEcCtD
Loperamide—Gastrointestinal disorder—Gemcitabine—breast cancer	4.46e-05	0.000874	CcSEcCtD
Loperamide—Discomfort—Paclitaxel—breast cancer	4.45e-05	0.000873	CcSEcCtD
Loperamide—Fatigue—Gemcitabine—breast cancer	4.45e-05	0.000872	CcSEcCtD
Loperamide—Constipation—Gemcitabine—breast cancer	4.41e-05	0.000865	CcSEcCtD
Loperamide—Dry mouth—Paclitaxel—breast cancer	4.41e-05	0.000864	CcSEcCtD
Loperamide—Asthenia—Thiotepa—breast cancer	4.4e-05	0.000863	CcSEcCtD
Loperamide—Diarrhoea—Vinorelbine—breast cancer	4.4e-05	0.000862	CcSEcCtD
Loperamide—Gastrointestinal disorder—Fluorouracil—breast cancer	4.38e-05	0.000859	CcSEcCtD
Loperamide—Abdominal distension—Epirubicin—breast cancer	4.37e-05	0.000857	CcSEcCtD
Loperamide—Nausea—Melphalan—breast cancer	4.37e-05	0.000856	CcSEcCtD
Loperamide—Clemastine—CYP2D6—breast cancer	4.37e-05	0.0259	CrCbGaD
Loperamide—Pruritus—Thiotepa—breast cancer	4.34e-05	0.000851	CcSEcCtD
Loperamide—Gastrointestinal pain—Irinotecan—breast cancer	4.33e-05	0.000849	CcSEcCtD
Loperamide—Gastrointestinal pain—Mitoxantrone—breast cancer	4.33e-05	0.000849	CcSEcCtD
Loperamide—Anaphylactic shock—Paclitaxel—breast cancer	4.32e-05	0.000847	CcSEcCtD
Loperamide—Flatulence—Capecitabine—breast cancer	4.28e-05	0.000839	CcSEcCtD
Loperamide—Levomethadyl Acetate—CYP19A1—breast cancer	4.27e-05	0.0254	CrCbGaD
Loperamide—Clotrimazole—CYP19A1—breast cancer	4.27e-05	0.0254	CrCbGaD
Loperamide—Nausea—Goserelin—breast cancer	4.26e-05	0.000835	CcSEcCtD
Loperamide—Dizziness—Vinorelbine—breast cancer	4.25e-05	0.000833	CcSEcCtD
Loperamide—Abdominal pain upper—Doxorubicin—breast cancer	4.25e-05	0.000833	CcSEcCtD
Loperamide—Nervous system disorder—Paclitaxel—breast cancer	4.24e-05	0.000831	CcSEcCtD
Loperamide—Urticaria—Mitoxantrone—breast cancer	4.21e-05	0.000825	CcSEcCtD
Loperamide—Diarrhoea—Thiotepa—breast cancer	4.2e-05	0.000823	CcSEcCtD
Loperamide—Skin disorder—Paclitaxel—breast cancer	4.2e-05	0.000823	CcSEcCtD
Loperamide—Abdominal pain—Irinotecan—breast cancer	4.19e-05	0.000821	CcSEcCtD
Loperamide—Abdominal pain—Mitoxantrone—breast cancer	4.19e-05	0.000821	CcSEcCtD
Loperamide—Toxic epidermal necrolysis—Doxorubicin—breast cancer	4.19e-05	0.000821	CcSEcCtD
Loperamide—Drowsiness—Methotrexate—breast cancer	4.14e-05	0.000811	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Methotrexate—breast cancer	4.1e-05	0.000804	CcSEcCtD
Loperamide—Vomiting—Vinorelbine—breast cancer	4.08e-05	0.000801	CcSEcCtD
Loperamide—Dizziness—Thiotepa—breast cancer	4.06e-05	0.000795	CcSEcCtD
Loperamide—Rash—Vinorelbine—breast cancer	4.05e-05	0.000794	CcSEcCtD
Loperamide—Dermatitis—Vinorelbine—breast cancer	4.05e-05	0.000793	CcSEcCtD
Loperamide—Abdominal distension—Doxorubicin—breast cancer	4.05e-05	0.000793	CcSEcCtD
Loperamide—Urticaria—Fluorouracil—breast cancer	4.03e-05	0.00079	CcSEcCtD
Loperamide—Headache—Vinorelbine—breast cancer	4.02e-05	0.000789	CcSEcCtD
Loperamide—Loss of consciousness—Docetaxel—breast cancer	3.94e-05	0.000773	CcSEcCtD
Loperamide—Hypersensitivity—Mitoxantrone—breast cancer	3.9e-05	0.000765	CcSEcCtD
Loperamide—Hypersensitivity—Irinotecan—breast cancer	3.9e-05	0.000765	CcSEcCtD
Loperamide—Vomiting—Thiotepa—breast cancer	3.9e-05	0.000765	CcSEcCtD
Loperamide—Drowsiness—Epirubicin—breast cancer	3.87e-05	0.000759	CcSEcCtD
Loperamide—Rash—Thiotepa—breast cancer	3.87e-05	0.000758	CcSEcCtD
Loperamide—Dermatitis—Thiotepa—breast cancer	3.86e-05	0.000758	CcSEcCtD
Loperamide—Headache—Thiotepa—breast cancer	3.84e-05	0.000754	CcSEcCtD
Loperamide—Somnolence—Paclitaxel—breast cancer	3.84e-05	0.000753	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Epirubicin—breast cancer	3.84e-05	0.000753	CcSEcCtD
Loperamide—Loss of consciousness—Capecitabine—breast cancer	3.82e-05	0.000749	CcSEcCtD
Loperamide—Nausea—Vinorelbine—breast cancer	3.82e-05	0.000748	CcSEcCtD
Loperamide—Dyspepsia—Paclitaxel—breast cancer	3.8e-05	0.000746	CcSEcCtD
Loperamide—Asthenia—Irinotecan—breast cancer	3.8e-05	0.000745	CcSEcCtD
Loperamide—Asthenia—Mitoxantrone—breast cancer	3.8e-05	0.000745	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	3.79e-05	0.000744	CcSEcCtD
Loperamide—Tamoxifen—ESR2—breast cancer	3.77e-05	0.0224	CrCbGaD
Loperamide—Clemastine—CYP3A4—breast cancer	3.75e-05	0.0222	CrCbGaD
Loperamide—Hypersensitivity—Fluorouracil—breast cancer	3.74e-05	0.000733	CcSEcCtD
Loperamide—Dry mouth—Docetaxel—breast cancer	3.74e-05	0.000733	CcSEcCtD
Loperamide—Gastrointestinal disorder—Paclitaxel—breast cancer	3.73e-05	0.000731	CcSEcCtD
Loperamide—Fatigue—Paclitaxel—breast cancer	3.73e-05	0.00073	CcSEcCtD
Loperamide—Asthenia—Gemcitabine—breast cancer	3.7e-05	0.000726	CcSEcCtD
Loperamide—Constipation—Paclitaxel—breast cancer	3.69e-05	0.000724	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	3.67e-05	0.00072	CcSEcCtD
Loperamide—Urinary tract disorder—Methotrexate—breast cancer	3.67e-05	0.000719	CcSEcCtD
Loperamide—Anaphylactic shock—Docetaxel—breast cancer	3.66e-05	0.000718	CcSEcCtD
Loperamide—Discomfort—Capecitabine—breast cancer	3.65e-05	0.000717	CcSEcCtD
Loperamide—Pruritus—Gemcitabine—breast cancer	3.65e-05	0.000716	CcSEcCtD
Loperamide—Nausea—Thiotepa—breast cancer	3.64e-05	0.000714	CcSEcCtD
Loperamide—Urethral disorder—Methotrexate—breast cancer	3.64e-05	0.000714	CcSEcCtD
Loperamide—Diarrhoea—Irinotecan—breast cancer	3.62e-05	0.000711	CcSEcCtD
Loperamide—Diarrhoea—Mitoxantrone—breast cancer	3.62e-05	0.000711	CcSEcCtD
Loperamide—Dry mouth—Capecitabine—breast cancer	3.62e-05	0.000709	CcSEcCtD
Loperamide—Nervous system disorder—Docetaxel—breast cancer	3.59e-05	0.000704	CcSEcCtD
Loperamide—Pruritus—Fluorouracil—breast cancer	3.59e-05	0.000704	CcSEcCtD
Loperamide—Drowsiness—Doxorubicin—breast cancer	3.58e-05	0.000703	CcSEcCtD
Loperamide—Skin disorder—Docetaxel—breast cancer	3.56e-05	0.000697	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Doxorubicin—breast cancer	3.55e-05	0.000697	CcSEcCtD
Loperamide—ABCB1—lymph node—breast cancer	3.55e-05	0.00235	CbGeAlD
Loperamide—Gastrointestinal pain—Paclitaxel—breast cancer	3.53e-05	0.000693	CcSEcCtD
Loperamide—Diarrhoea—Gemcitabine—breast cancer	3.53e-05	0.000692	CcSEcCtD
Loperamide—Erythema multiforme—Methotrexate—breast cancer	3.51e-05	0.000689	CcSEcCtD
Loperamide—Dizziness—Irinotecan—breast cancer	3.5e-05	0.000687	CcSEcCtD
Loperamide—Nervous system disorder—Capecitabine—breast cancer	3.48e-05	0.000682	CcSEcCtD
Loperamide—Diarrhoea—Fluorouracil—breast cancer	3.47e-05	0.000681	CcSEcCtD
Loperamide—Skin disorder—Capecitabine—breast cancer	3.44e-05	0.000675	CcSEcCtD
Loperamide—Tamoxifen—CYP1B1—breast cancer	3.44e-05	0.0204	CrCbGaD
Loperamide—Urinary tract disorder—Epirubicin—breast cancer	3.43e-05	0.000673	CcSEcCtD
Loperamide—Urticaria—Paclitaxel—breast cancer	3.43e-05	0.000673	CcSEcCtD
Loperamide—Abdominal pain—Paclitaxel—breast cancer	3.42e-05	0.00067	CcSEcCtD
Loperamide—Urethral disorder—Epirubicin—breast cancer	3.41e-05	0.000668	CcSEcCtD
Loperamide—Vomiting—Irinotecan—breast cancer	3.37e-05	0.00066	CcSEcCtD
Loperamide—Vomiting—Mitoxantrone—breast cancer	3.37e-05	0.00066	CcSEcCtD
Loperamide—Immune system disorder—Methotrexate—breast cancer	3.36e-05	0.000658	CcSEcCtD
Loperamide—Dizziness—Fluorouracil—breast cancer	3.36e-05	0.000658	CcSEcCtD
Loperamide—Rash—Mitoxantrone—breast cancer	3.34e-05	0.000655	CcSEcCtD
Loperamide—Rash—Irinotecan—breast cancer	3.34e-05	0.000655	CcSEcCtD
Loperamide—Dermatitis—Mitoxantrone—breast cancer	3.34e-05	0.000654	CcSEcCtD
Loperamide—Dermatitis—Irinotecan—breast cancer	3.34e-05	0.000654	CcSEcCtD
Loperamide—Headache—Irinotecan—breast cancer	3.32e-05	0.000651	CcSEcCtD
Loperamide—Headache—Mitoxantrone—breast cancer	3.32e-05	0.000651	CcSEcCtD
Loperamide—Erythema multiforme—Epirubicin—breast cancer	3.29e-05	0.000645	CcSEcCtD
Loperamide—Vomiting—Gemcitabine—breast cancer	3.28e-05	0.000643	CcSEcCtD
Loperamide—Somnolence—Docetaxel—breast cancer	3.26e-05	0.000638	CcSEcCtD
Loperamide—Rash—Gemcitabine—breast cancer	3.25e-05	0.000638	CcSEcCtD
Loperamide—Dermatitis—Gemcitabine—breast cancer	3.25e-05	0.000637	CcSEcCtD
Loperamide—Headache—Gemcitabine—breast cancer	3.23e-05	0.000634	CcSEcCtD
Loperamide—Vomiting—Fluorouracil—breast cancer	3.23e-05	0.000633	CcSEcCtD
Loperamide—Dyspepsia—Docetaxel—breast cancer	3.22e-05	0.000632	CcSEcCtD
Loperamide—Rash—Fluorouracil—breast cancer	3.2e-05	0.000627	CcSEcCtD
Loperamide—Dermatitis—Fluorouracil—breast cancer	3.2e-05	0.000627	CcSEcCtD
Loperamide—Hypersensitivity—Paclitaxel—breast cancer	3.18e-05	0.000624	CcSEcCtD
Loperamide—Headache—Fluorouracil—breast cancer	3.18e-05	0.000623	CcSEcCtD
Loperamide—Urinary tract disorder—Doxorubicin—breast cancer	3.18e-05	0.000623	CcSEcCtD
Loperamide—Gastrointestinal disorder—Docetaxel—breast cancer	3.16e-05	0.00062	CcSEcCtD
Loperamide—Fatigue—Docetaxel—breast cancer	3.16e-05	0.000619	CcSEcCtD
Loperamide—Urethral disorder—Doxorubicin—breast cancer	3.15e-05	0.000618	CcSEcCtD
Loperamide—Nausea—Mitoxantrone—breast cancer	3.15e-05	0.000617	CcSEcCtD
Loperamide—Nausea—Irinotecan—breast cancer	3.15e-05	0.000617	CcSEcCtD
Loperamide—Immune system disorder—Epirubicin—breast cancer	3.14e-05	0.000616	CcSEcCtD
Loperamide—Constipation—Docetaxel—breast cancer	3.13e-05	0.000614	CcSEcCtD
Loperamide—Dyspepsia—Capecitabine—breast cancer	3.12e-05	0.000612	CcSEcCtD
Loperamide—Darifenacin—CYP2D6—breast cancer	3.11e-05	0.0185	CrCbGaD
Loperamide—Asthenia—Paclitaxel—breast cancer	3.1e-05	0.000608	CcSEcCtD
Loperamide—Nausea—Gemcitabine—breast cancer	3.07e-05	0.000601	CcSEcCtD
Loperamide—Gastrointestinal disorder—Capecitabine—breast cancer	3.06e-05	0.0006	CcSEcCtD
Loperamide—Fatigue—Capecitabine—breast cancer	3.06e-05	0.000599	CcSEcCtD
Loperamide—Pruritus—Paclitaxel—breast cancer	3.06e-05	0.000599	CcSEcCtD
Loperamide—Erythema multiforme—Doxorubicin—breast cancer	3.04e-05	0.000596	CcSEcCtD
Loperamide—Constipation—Capecitabine—breast cancer	3.03e-05	0.000595	CcSEcCtD
Loperamide—Fexofenadine—CYP2D6—breast cancer	3.03e-05	0.018	CrCbGaD
Loperamide—Nausea—Fluorouracil—breast cancer	3.01e-05	0.000591	CcSEcCtD
Loperamide—Gastrointestinal pain—Docetaxel—breast cancer	2.99e-05	0.000587	CcSEcCtD
Loperamide—Flatulence—Epirubicin—breast cancer	2.98e-05	0.000585	CcSEcCtD
Loperamide—Toremifene—CYP3A4—breast cancer	2.97e-05	0.0176	CrCbGaD
Loperamide—Diarrhoea—Paclitaxel—breast cancer	2.96e-05	0.00058	CcSEcCtD
Loperamide—Immune system disorder—Doxorubicin—breast cancer	2.91e-05	0.00057	CcSEcCtD
Loperamide—Gastrointestinal pain—Capecitabine—breast cancer	2.9e-05	0.000568	CcSEcCtD
Loperamide—Abdominal pain—Docetaxel—breast cancer	2.9e-05	0.000568	CcSEcCtD
Loperamide—Dizziness—Paclitaxel—breast cancer	2.86e-05	0.00056	CcSEcCtD
Loperamide—Haloperidol—CYP1A1—breast cancer	2.83e-05	0.0168	CrCbGaD
Loperamide—Urticaria—Capecitabine—breast cancer	2.82e-05	0.000552	CcSEcCtD
Loperamide—Abdominal pain—Capecitabine—breast cancer	2.8e-05	0.00055	CcSEcCtD
Loperamide—Flatulence—Doxorubicin—breast cancer	2.76e-05	0.000541	CcSEcCtD
Loperamide—Vomiting—Paclitaxel—breast cancer	2.75e-05	0.000539	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.73e-05	0.000536	CcSEcCtD
Loperamide—Rash—Paclitaxel—breast cancer	2.72e-05	0.000534	CcSEcCtD
Loperamide—Dermatitis—Paclitaxel—breast cancer	2.72e-05	0.000534	CcSEcCtD
Loperamide—Discomfort—Methotrexate—breast cancer	2.72e-05	0.000533	CcSEcCtD
Loperamide—Headache—Paclitaxel—breast cancer	2.71e-05	0.000531	CcSEcCtD
Loperamide—Hypersensitivity—Docetaxel—breast cancer	2.7e-05	0.000529	CcSEcCtD
Loperamide—Darifenacin—CYP3A4—breast cancer	2.67e-05	0.0158	CrCbGaD
Loperamide—Loss of consciousness—Epirubicin—breast cancer	2.66e-05	0.000522	CcSEcCtD
Loperamide—Anaphylactic shock—Methotrexate—breast cancer	2.64e-05	0.000518	CcSEcCtD
Loperamide—Asthenia—Docetaxel—breast cancer	2.63e-05	0.000515	CcSEcCtD
Loperamide—Hypersensitivity—Capecitabine—breast cancer	2.61e-05	0.000512	CcSEcCtD
Loperamide—Pruritus—Docetaxel—breast cancer	2.59e-05	0.000508	CcSEcCtD
Loperamide—Nervous system disorder—Methotrexate—breast cancer	2.59e-05	0.000508	CcSEcCtD
Loperamide—Nausea—Paclitaxel—breast cancer	2.57e-05	0.000503	CcSEcCtD
Loperamide—Skin disorder—Methotrexate—breast cancer	2.56e-05	0.000503	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.56e-05	0.000502	CcSEcCtD
Loperamide—Discomfort—Epirubicin—breast cancer	2.55e-05	0.000499	CcSEcCtD
Loperamide—Asthenia—Capecitabine—breast cancer	2.54e-05	0.000499	CcSEcCtD
Loperamide—Tamoxifen—CYP19A1—breast cancer	2.53e-05	0.015	CrCbGaD
Loperamide—Dry mouth—Epirubicin—breast cancer	2.52e-05	0.000494	CcSEcCtD
Loperamide—Pruritus—Capecitabine—breast cancer	2.51e-05	0.000492	CcSEcCtD
Loperamide—Diarrhoea—Docetaxel—breast cancer	2.51e-05	0.000491	CcSEcCtD
Loperamide—Methadone—CYP19A1—breast cancer	2.5e-05	0.0149	CrCbGaD
Loperamide—Toremifene—ABCB1—breast cancer	2.47e-05	0.0147	CrCbGaD
Loperamide—Anaphylactic shock—Epirubicin—breast cancer	2.47e-05	0.000484	CcSEcCtD
Loperamide—Loss of consciousness—Doxorubicin—breast cancer	2.46e-05	0.000483	CcSEcCtD
Loperamide—Diarrhoea—Capecitabine—breast cancer	2.43e-05	0.000476	CcSEcCtD
Loperamide—Nervous system disorder—Epirubicin—breast cancer	2.42e-05	0.000475	CcSEcCtD
Loperamide—Dizziness—Docetaxel—breast cancer	2.42e-05	0.000475	CcSEcCtD
Loperamide—Skin disorder—Epirubicin—breast cancer	2.4e-05	0.00047	CcSEcCtD
Loperamide—Tamoxifen—ABCG2—breast cancer	2.37e-05	0.0141	CrCbGaD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.37e-05	0.000464	CcSEcCtD
Loperamide—Discomfort—Doxorubicin—breast cancer	2.36e-05	0.000462	CcSEcCtD
Loperamide—Somnolence—Methotrexate—breast cancer	2.35e-05	0.00046	CcSEcCtD
Loperamide—Dizziness—Capecitabine—breast cancer	2.34e-05	0.00046	CcSEcCtD
Loperamide—Clotrimazole—CYP2D6—breast cancer	2.34e-05	0.0139	CrCbGaD
Loperamide—Dry mouth—Doxorubicin—breast cancer	2.33e-05	0.000457	CcSEcCtD
Loperamide—Vomiting—Docetaxel—breast cancer	2.33e-05	0.000457	CcSEcCtD
Loperamide—Tamoxifen—ESR1—breast cancer	2.32e-05	0.0138	CrCbGaD
Loperamide—Dyspepsia—Methotrexate—breast cancer	2.32e-05	0.000456	CcSEcCtD
Loperamide—Rash—Docetaxel—breast cancer	2.31e-05	0.000453	CcSEcCtD
Loperamide—Dermatitis—Docetaxel—breast cancer	2.31e-05	0.000452	CcSEcCtD
Loperamide—Headache—Docetaxel—breast cancer	2.29e-05	0.00045	CcSEcCtD
Loperamide—Anaphylactic shock—Doxorubicin—breast cancer	2.29e-05	0.000448	CcSEcCtD
Loperamide—Gastrointestinal disorder—Methotrexate—breast cancer	2.28e-05	0.000447	CcSEcCtD
Loperamide—Fatigue—Methotrexate—breast cancer	2.28e-05	0.000446	CcSEcCtD
Loperamide—Vomiting—Capecitabine—breast cancer	2.25e-05	0.000442	CcSEcCtD
Loperamide—Nervous system disorder—Doxorubicin—breast cancer	2.24e-05	0.000439	CcSEcCtD
Loperamide—Rash—Capecitabine—breast cancer	2.24e-05	0.000438	CcSEcCtD
Loperamide—Dermatitis—Capecitabine—breast cancer	2.23e-05	0.000438	CcSEcCtD
Loperamide—Headache—Capecitabine—breast cancer	2.22e-05	0.000436	CcSEcCtD
Loperamide—Skin disorder—Doxorubicin—breast cancer	2.22e-05	0.000435	CcSEcCtD
Loperamide—Somnolence—Epirubicin—breast cancer	2.2e-05	0.000431	CcSEcCtD
Loperamide—Nausea—Docetaxel—breast cancer	2.18e-05	0.000427	CcSEcCtD
Loperamide—Dyspepsia—Epirubicin—breast cancer	2.17e-05	0.000426	CcSEcCtD
Loperamide—Fexofenadine—ABCB1—breast cancer	2.16e-05	0.0128	CrCbGaD
Loperamide—Gastrointestinal pain—Methotrexate—breast cancer	2.16e-05	0.000423	CcSEcCtD
Loperamide—Gastrointestinal disorder—Epirubicin—breast cancer	2.13e-05	0.000418	CcSEcCtD
Loperamide—Fatigue—Epirubicin—breast cancer	2.13e-05	0.000418	CcSEcCtD
Loperamide—Constipation—Epirubicin—breast cancer	2.11e-05	0.000414	CcSEcCtD
Loperamide—Nausea—Capecitabine—breast cancer	2.11e-05	0.000413	CcSEcCtD
Loperamide—Haloperidol—CYP2D6—breast cancer	2.11e-05	0.0125	CrCbGaD
Loperamide—Urticaria—Methotrexate—breast cancer	2.1e-05	0.000411	CcSEcCtD
Loperamide—Abdominal pain—Methotrexate—breast cancer	2.09e-05	0.000409	CcSEcCtD
Loperamide—Somnolence—Doxorubicin—breast cancer	2.03e-05	0.000398	CcSEcCtD
Loperamide—Dextropropoxyphene—CYP2D6—breast cancer	2.02e-05	0.012	CrCbGaD
Loperamide—Gastrointestinal pain—Epirubicin—breast cancer	2.02e-05	0.000396	CcSEcCtD
Loperamide—Dyspepsia—Doxorubicin—breast cancer	2.01e-05	0.000394	CcSEcCtD
Loperamide—Clotrimazole—CYP3A4—breast cancer	2.01e-05	0.0119	CrCbGaD
Loperamide—Levomethadyl Acetate—CYP3A4—breast cancer	2.01e-05	0.0119	CrCbGaD
Loperamide—Gastrointestinal disorder—Doxorubicin—breast cancer	1.97e-05	0.000387	CcSEcCtD
Loperamide—Fatigue—Doxorubicin—breast cancer	1.97e-05	0.000386	CcSEcCtD
Loperamide—Urticaria—Epirubicin—breast cancer	1.96e-05	0.000385	CcSEcCtD
Loperamide—Constipation—Doxorubicin—breast cancer	1.95e-05	0.000383	CcSEcCtD
Loperamide—Abdominal pain—Epirubicin—breast cancer	1.95e-05	0.000383	CcSEcCtD
Loperamide—Hypersensitivity—Methotrexate—breast cancer	1.94e-05	0.000381	CcSEcCtD
Loperamide—Asthenia—Methotrexate—breast cancer	1.89e-05	0.000371	CcSEcCtD
Loperamide—Gastrointestinal pain—Doxorubicin—breast cancer	1.87e-05	0.000366	CcSEcCtD
Loperamide—Pruritus—Methotrexate—breast cancer	1.87e-05	0.000366	CcSEcCtD
Loperamide—Tamoxifen—CYP1A1—breast cancer	1.86e-05	0.011	CrCbGaD
Loperamide—Hypersensitivity—Epirubicin—breast cancer	1.82e-05	0.000357	CcSEcCtD
Loperamide—Urticaria—Doxorubicin—breast cancer	1.82e-05	0.000356	CcSEcCtD
Loperamide—Abdominal pain—Doxorubicin—breast cancer	1.81e-05	0.000354	CcSEcCtD
Loperamide—Haloperidol—CYP3A4—breast cancer	1.81e-05	0.0107	CrCbGaD
Loperamide—Diarrhoea—Methotrexate—breast cancer	1.81e-05	0.000354	CcSEcCtD
Loperamide—Asthenia—Epirubicin—breast cancer	1.77e-05	0.000347	CcSEcCtD
Loperamide—Pruritus—Epirubicin—breast cancer	1.75e-05	0.000343	CcSEcCtD
Loperamide—Dizziness—Methotrexate—breast cancer	1.75e-05	0.000342	CcSEcCtD
Loperamide—Dextropropoxyphene—CYP3A4—breast cancer	1.73e-05	0.0103	CrCbGaD
Loperamide—Fentanyl—CYP3A4—breast cancer	1.72e-05	0.0102	CrCbGaD
Loperamide—Diarrhoea—Epirubicin—breast cancer	1.69e-05	0.000331	CcSEcCtD
Loperamide—Hypersensitivity—Doxorubicin—breast cancer	1.68e-05	0.00033	CcSEcCtD
Loperamide—Vomiting—Methotrexate—breast cancer	1.68e-05	0.000329	CcSEcCtD
Loperamide—Clotrimazole—ABCB1—breast cancer	1.67e-05	0.00992	CrCbGaD
Loperamide—Rash—Methotrexate—breast cancer	1.66e-05	0.000326	CcSEcCtD
Loperamide—Dermatitis—Methotrexate—breast cancer	1.66e-05	0.000326	CcSEcCtD
Loperamide—Headache—Methotrexate—breast cancer	1.65e-05	0.000324	CcSEcCtD
Loperamide—Asthenia—Doxorubicin—breast cancer	1.64e-05	0.000322	CcSEcCtD
Loperamide—Dizziness—Epirubicin—breast cancer	1.63e-05	0.00032	CcSEcCtD
Loperamide—Pruritus—Doxorubicin—breast cancer	1.62e-05	0.000317	CcSEcCtD
Loperamide—Vomiting—Epirubicin—breast cancer	1.57e-05	0.000308	CcSEcCtD
Loperamide—Nausea—Methotrexate—breast cancer	1.57e-05	0.000307	CcSEcCtD
Loperamide—Diarrhoea—Doxorubicin—breast cancer	1.56e-05	0.000307	CcSEcCtD
Loperamide—Rash—Epirubicin—breast cancer	1.56e-05	0.000305	CcSEcCtD
Loperamide—Dermatitis—Epirubicin—breast cancer	1.56e-05	0.000305	CcSEcCtD
Loperamide—Headache—Epirubicin—breast cancer	1.55e-05	0.000303	CcSEcCtD
Loperamide—Dizziness—Doxorubicin—breast cancer	1.51e-05	0.000296	CcSEcCtD
Loperamide—Haloperidol—ABCB1—breast cancer	1.5e-05	0.00893	CrCbGaD
Loperamide—Nausea—Epirubicin—breast cancer	1.47e-05	0.000288	CcSEcCtD
Loperamide—Vomiting—Doxorubicin—breast cancer	1.45e-05	0.000285	CcSEcCtD
Loperamide—Rash—Doxorubicin—breast cancer	1.44e-05	0.000283	CcSEcCtD
Loperamide—Dermatitis—Doxorubicin—breast cancer	1.44e-05	0.000282	CcSEcCtD
Loperamide—Headache—Doxorubicin—breast cancer	1.43e-05	0.000281	CcSEcCtD
Loperamide—Fentanyl—ABCB1—breast cancer	1.43e-05	0.00848	CrCbGaD
Loperamide—Tamoxifen—CYP2D6—breast cancer	1.38e-05	0.00821	CrCbGaD
Loperamide—Methadone—CYP2D6—breast cancer	1.37e-05	0.00814	CrCbGaD
Loperamide—Nausea—Doxorubicin—breast cancer	1.36e-05	0.000266	CcSEcCtD
Loperamide—Tamoxifen—CYP3A4—breast cancer	1.19e-05	0.00704	CrCbGaD
Loperamide—Methadone—CYP3A4—breast cancer	1.18e-05	0.00698	CrCbGaD
Loperamide—Tamoxifen—ABCB1—breast cancer	9.88e-06	0.00586	CrCbGaD
Loperamide—Methadone—ABCB1—breast cancer	9.79e-06	0.00581	CrCbGaD
Loperamide—CALM1—Immune System—STAT3—breast cancer	5.26e-07	8.85e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—STAT3—breast cancer	5.26e-07	8.85e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF1—breast cancer	5.26e-07	8.84e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF1—breast cancer	5.26e-07	8.84e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AKT2—breast cancer	5.26e-07	8.84e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AKT2—breast cancer	5.26e-07	8.84e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—STK11—breast cancer	5.25e-07	8.83e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP19A1—breast cancer	5.25e-07	8.83e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—EGFR—breast cancer	5.23e-07	8.8e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—EGFR—breast cancer	5.23e-07	8.8e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PIK3CD—breast cancer	5.22e-07	8.78e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTGS2—breast cancer	5.22e-07	8.77e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTGS2—breast cancer	5.22e-07	8.77e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—SRC—breast cancer	5.21e-07	8.76e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—MAPK3—breast cancer	5.2e-07	8.74e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SERPINE1—breast cancer	5.16e-07	8.68e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—EGFR—breast cancer	5.16e-07	8.68e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—breast cancer	5.13e-07	8.62e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—NOS3—breast cancer	5.13e-07	8.62e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—KRAS—breast cancer	5.11e-07	8.59e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PIK3CG—breast cancer	5.07e-07	8.53e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PIK3CD—breast cancer	5.05e-07	8.49e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PIK3CD—breast cancer	5.05e-07	8.49e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—SRC—breast cancer	5.04e-07	8.47e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—SRC—breast cancer	5.04e-07	8.47e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—MAPK3—breast cancer	5.03e-07	8.45e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—MAPK3—breast cancer	5.03e-07	8.45e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—STAT3—breast cancer	5.02e-07	8.44e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SERPINE1—breast cancer	5e-07	8.4e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SERPINE1—breast cancer	5e-07	8.4e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—KRAS—breast cancer	4.94e-07	8.31e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—KRAS—breast cancer	4.94e-07	8.31e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—EGFR—breast cancer	4.94e-07	8.31e-06	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AKT1—breast cancer	4.94e-07	8.31e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NOS3—breast cancer	4.93e-07	8.29e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HRAS—breast cancer	4.91e-07	8.25e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—COMT—breast cancer	4.88e-07	8.21e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—KRAS—breast cancer	4.88e-07	8.2e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTP1—breast cancer	4.86e-07	8.17e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—STAT3—breast cancer	4.86e-07	8.17e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—STAT3—breast cancer	4.86e-07	8.17e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTEN—breast cancer	4.83e-07	8.12e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—MAPK3—breast cancer	4.8e-07	8.07e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—HMOX1—breast cancer	4.79e-07	8.06e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—EGFR—breast cancer	4.78e-07	8.04e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—EGFR—breast cancer	4.78e-07	8.04e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ITPR1—breast cancer	4.78e-07	8.04e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NOS3—breast cancer	4.77e-07	8.02e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NOS3—breast cancer	4.77e-07	8.02e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PIK3CB—breast cancer	4.73e-07	7.96e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PIK3CD—breast cancer	4.73e-07	7.96e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTEN—breast cancer	4.7e-07	7.91e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—PIK3CA—breast cancer	4.7e-07	7.9e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL6—breast cancer	4.7e-07	7.89e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS2—breast cancer	4.69e-07	7.89e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MDM2—breast cancer	4.68e-07	7.86e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ALB—breast cancer	4.67e-07	7.85e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—KRAS—breast cancer	4.67e-07	7.85e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—MYC—breast cancer	4.67e-07	7.85e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—RAF1—breast cancer	4.66e-07	7.84e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—TGFB1—breast cancer	4.66e-07	7.83e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—MAPK3—breast cancer	4.64e-07	7.8e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—MAPK3—breast cancer	4.64e-07	7.8e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—RELA—breast cancer	4.64e-07	7.8e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ERBB2—breast cancer	4.61e-07	7.75e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ABCB1—breast cancer	4.6e-07	7.73e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—EGFR—breast cancer	4.56e-07	7.67e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MTOR—breast cancer	4.55e-07	7.65e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PIK3CB—breast cancer	4.55e-07	7.65e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTEN—breast cancer	4.55e-07	7.65e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTEN—breast cancer	4.55e-07	7.65e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—PIK3CA—breast cancer	4.54e-07	7.64e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—PIK3CA—breast cancer	4.54e-07	7.64e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MDM2—breast cancer	4.52e-07	7.61e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MDM2—breast cancer	4.52e-07	7.61e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—TYMS—breast cancer	4.52e-07	7.6e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—KRAS—breast cancer	4.52e-07	7.6e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—KRAS—breast cancer	4.52e-07	7.6e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—MYC—breast cancer	4.51e-07	7.59e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—MYC—breast cancer	4.51e-07	7.59e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—RAF1—breast cancer	4.51e-07	7.58e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—RAF1—breast cancer	4.51e-07	7.58e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—TGFB1—breast cancer	4.5e-07	7.57e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—TGFB1—breast cancer	4.5e-07	7.57e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—RELA—breast cancer	4.49e-07	7.55e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—RELA—breast cancer	4.49e-07	7.55e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—PIK3CA—breast cancer	4.48e-07	7.53e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—NOS3—breast cancer	4.47e-07	7.51e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PLA2G4A—breast cancer	4.47e-07	7.51e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTM1—breast cancer	4.47e-07	7.51e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NCOR1—breast cancer	4.47e-07	7.51e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ERBB2—breast cancer	4.46e-07	7.5e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ERBB2—breast cancer	4.46e-07	7.5e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PIK3CD—breast cancer	4.46e-07	7.5e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—EGFR—breast cancer	4.42e-07	7.42e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—EGFR—breast cancer	4.42e-07	7.42e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PIK3CB—breast cancer	4.4e-07	7.4e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MTOR—breast cancer	4.4e-07	7.4e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PIK3CB—breast cancer	4.4e-07	7.4e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MTOR—breast cancer	4.4e-07	7.4e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ALB—breast cancer	4.4e-07	7.4e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CXCL8—breast cancer	4.37e-07	7.35e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HRAS—breast cancer	4.34e-07	7.3e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—breast cancer	4.34e-07	7.29e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AKT1—breast cancer	4.33e-07	7.28e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—KRAS—breast cancer	4.31e-07	7.25e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—PIK3CA—breast cancer	4.29e-07	7.21e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GPX1—breast cancer	4.28e-07	7.19e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CDKN1B—breast cancer	4.27e-07	7.18e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP1A1—breast cancer	4.23e-07	7.12e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CXCL8—breast cancer	4.23e-07	7.11e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CXCL8—breast cancer	4.23e-07	7.11e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—NOS3—breast cancer	4.21e-07	7.08e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HRAS—breast cancer	4.2e-07	7.07e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HRAS—breast cancer	4.2e-07	7.07e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ERCC2—breast cancer	4.2e-07	7.06e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CASP3—breast cancer	4.19e-07	7.04e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL2—breast cancer	4.18e-07	7.03e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—KRAS—breast cancer	4.17e-07	7.01e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—KRAS—breast cancer	4.17e-07	7.01e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL6—breast cancer	4.16e-07	6.99e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—PIK3CA—breast cancer	4.15e-07	6.98e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—PIK3CA—breast cancer	4.15e-07	6.98e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HRAS—breast cancer	4.15e-07	6.97e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CDKN1B—breast cancer	4.13e-07	6.95e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CDKN1B—breast cancer	4.13e-07	6.95e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PIK3CB—breast cancer	4.12e-07	6.93e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTEN—breast cancer	4.09e-07	6.88e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS2—breast cancer	4.09e-07	6.87e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCND1—breast cancer	4.07e-07	6.85e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—JUN—breast cancer	4.07e-07	6.83e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CASP3—breast cancer	4.05e-07	6.81e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CASP3—breast cancer	4.05e-07	6.81e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL2—breast cancer	4.04e-07	6.8e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL2—breast cancer	4.04e-07	6.8e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CTNNB1—breast cancer	4.03e-07	6.78e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6—breast cancer	4.02e-07	6.76e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6—breast cancer	4.02e-07	6.76e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—HRAS—breast cancer	3.97e-07	6.67e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6—breast cancer	3.97e-07	6.67e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—PIK3CA—breast cancer	3.96e-07	6.66e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP9—breast cancer	3.96e-07	6.65e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MTHFR—breast cancer	3.95e-07	6.64e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CDKN1A—breast cancer	3.94e-07	6.63e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCND1—breast cancer	3.94e-07	6.63e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCND1—breast cancer	3.94e-07	6.63e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—JUN—breast cancer	3.93e-07	6.61e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—JUN—breast cancer	3.93e-07	6.61e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PTEN—breast cancer	3.93e-07	6.61e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CTNNB1—breast cancer	3.9e-07	6.56e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CTNNB1—breast cancer	3.9e-07	6.56e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PIK3CB—breast cancer	3.89e-07	6.53e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS2—breast cancer	3.85e-07	6.47e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MAPK8—breast cancer	3.85e-07	6.47e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—HRAS—breast cancer	3.84e-07	6.46e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—HRAS—breast cancer	3.84e-07	6.46e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AKT1—breast cancer	3.84e-07	6.45e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—PIK3CA—breast cancer	3.83e-07	6.44e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—PIK3CA—breast cancer	3.83e-07	6.44e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP9—breast cancer	3.83e-07	6.43e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP9—breast cancer	3.83e-07	6.43e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CDKN1A—breast cancer	3.81e-07	6.41e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CDKN1A—breast cancer	3.81e-07	6.41e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PTEN—breast cancer	3.8e-07	6.4e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PTEN—breast cancer	3.8e-07	6.4e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6—breast cancer	3.8e-07	6.39e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAPK8—breast cancer	3.72e-07	6.26e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MAPK8—breast cancer	3.72e-07	6.26e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AKT1—breast cancer	3.71e-07	6.24e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AKT1—breast cancer	3.71e-07	6.24e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6—breast cancer	3.68e-07	6.18e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6—breast cancer	3.68e-07	6.18e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—HRAS—breast cancer	3.67e-07	6.16e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AKT1—breast cancer	3.66e-07	6.15e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SRC—breast cancer	3.65e-07	6.13e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CAV1—breast cancer	3.64e-07	6.12e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTEN—breast cancer	3.56e-07	5.99e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—VEGFA—breast cancer	3.55e-07	5.97e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—HRAS—breast cancer	3.55e-07	5.96e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—HRAS—breast cancer	3.55e-07	5.96e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SRC—breast cancer	3.53e-07	5.93e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SRC—breast cancer	3.53e-07	5.93e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—STAT3—breast cancer	3.52e-07	5.91e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6—breast cancer	3.51e-07	5.9e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—AKT1—breast cancer	3.51e-07	5.89e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—VEGFA—breast cancer	3.44e-07	5.78e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—VEGFA—breast cancer	3.44e-07	5.78e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PIK3CA—breast cancer	3.41e-07	5.73e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—STAT3—breast cancer	3.4e-07	5.72e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—STAT3—breast cancer	3.4e-07	5.72e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6—breast cancer	3.39e-07	5.7e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6—breast cancer	3.39e-07	5.7e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—AKT1—breast cancer	3.39e-07	5.7e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—AKT1—breast cancer	3.39e-07	5.7e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MAPK3—breast cancer	3.36e-07	5.65e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTEN—breast cancer	3.36e-07	5.65e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PIK3CA—breast cancer	3.32e-07	5.58e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PIK3CG—breast cancer	3.32e-07	5.58e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MYC—breast cancer	3.27e-07	5.49e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TGFB1—breast cancer	3.26e-07	5.48e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAPK3—breast cancer	3.25e-07	5.46e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MAPK3—breast cancer	3.25e-07	5.46e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—AKT1—breast cancer	3.24e-07	5.44e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PIK3CA—breast cancer	3.21e-07	5.4e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PIK3CA—breast cancer	3.21e-07	5.4e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EGFR—breast cancer	3.2e-07	5.37e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MYC—breast cancer	3.16e-07	5.31e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MYC—breast cancer	3.16e-07	5.31e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TGFB1—breast cancer	3.15e-07	5.3e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TGFB1—breast cancer	3.15e-07	5.3e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—AKT1—breast cancer	3.13e-07	5.26e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—AKT1—breast cancer	3.13e-07	5.26e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EGFR—breast cancer	3.09e-07	5.2e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EGFR—breast cancer	3.09e-07	5.2e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—KRAS—breast cancer	3.02e-07	5.08e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—KRAS—breast cancer	2.92e-07	4.91e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—KRAS—breast cancer	2.92e-07	4.91e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PIK3CD—breast cancer	2.92e-07	4.9e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PIK3CA—breast cancer	2.89e-07	4.85e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ALB—breast cancer	2.88e-07	4.84e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AKT1—breast cancer	2.78e-07	4.68e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PIK3CA—breast cancer	2.77e-07	4.66e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—NOS3—breast cancer	2.75e-07	4.63e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AKT1—breast cancer	2.71e-07	4.56e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—breast cancer	2.68e-07	4.51e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PIK3CA—breast cancer	2.68e-07	4.51e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PIK3CA—breast cancer	2.68e-07	4.51e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AKT1—breast cancer	2.62e-07	4.41e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AKT1—breast cancer	2.62e-07	4.41e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—breast cancer	2.6e-07	4.36e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—breast cancer	2.6e-07	4.36e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HRAS—breast cancer	2.57e-07	4.31e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PIK3CB—breast cancer	2.54e-07	4.27e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS2—breast cancer	2.52e-07	4.23e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PIK3CA—breast cancer	2.51e-07	4.23e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HRAS—breast cancer	2.48e-07	4.17e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HRAS—breast cancer	2.48e-07	4.17e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6—breast cancer	2.46e-07	4.13e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6—breast cancer	2.38e-07	4e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6—breast cancer	2.38e-07	4e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PIK3CA—breast cancer	2.37e-07	3.98e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AKT1—breast cancer	2.36e-07	3.96e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AKT1—breast cancer	2.27e-07	3.81e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTEN—breast cancer	2.2e-07	3.69e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AKT1—breast cancer	2.19e-07	3.69e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AKT1—breast cancer	2.19e-07	3.69e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AKT1—breast cancer	2.05e-07	3.45e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AKT1—breast cancer	1.94e-07	3.25e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PIK3CA—breast cancer	1.55e-07	2.6e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AKT1—breast cancer	1.27e-07	2.13e-06	CbGpPWpGaD
